{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:59:54Z","timestamp":1792670394634,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.clinthera.2018.03.013","type":"journal-article","created":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T19:47:41Z","timestamp":1523994461000},"page":"1448-1456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["The Psychiatric Consequences of Cannabinoids"],"prefix":"10.1016","volume":"40","author":[{"given":"Joao P.","family":"De Aquino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Sherif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Cahill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohini","family":"Ranganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak C.","family":"D\u2019Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2018.03.013_bib1","series-title":"Results from the 2012 National Survey on Drug Use and Health: Summary of national findings, in NSDUH Series H-46, HHS Publication No.(SMA) 13-4795","author":"Abuse","year":"2013"},{"key":"10.1016\/j.clinthera.2018.03.013_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.drugpo.2014.09.007","article-title":"Medical Marijuana programs: implications for cannabis control policy--observations from Canada","volume":"26","author":"Fischer","year":"2015","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.clinthera.2018.03.013_bib3","series-title":"Handbook of Cannabis","first-page":"1093","article-title":"Constituents of cannabis sativa","author":"ElSohly","year":"2014"},{"key":"10.1016\/j.clinthera.2018.03.013_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev-psych-113011-143739","article-title":"The endocannabinoid system and the brain","volume":"64","author":"Mechoulam","year":"2013","journal-title":"Annu Rev Psychol"},{"key":"10.1016\/j.clinthera.2018.03.013_bib5","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S2215-0366(17)30075-5","article-title":"Can we make cannabis safer?","volume":"4","author":"Englund","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.clinthera.2018.03.013_bib6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/npp.2017.209","article-title":"clinical and preclinical evidence for functional interactions of cannabidiol and delta(9)-tetrahydrocannabinol","volume":"43","author":"Boggs","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.clinthera.2018.03.013_bib7","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1038\/npp.2012.123","article-title":"Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA(B) receptors in the balance of GABAergic and glutamatergic neurotransmission","volume":"37","author":"Rey","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.clinthera.2018.03.013_bib8","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.biopsych.2016.01.004","article-title":"Changes in cannabis potency over the last 2 decades (1995-2014): analysis of current data in the United States","volume":"79","author":"ElSohly","year":"2016","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.clinthera.2018.03.013_bib9","doi-asserted-by":"crossref","first-page":"9988","DOI":"10.3390\/ijerph120809988","article-title":"E-Cigarettes: A Review of New Trends in Cannabis Use","volume":"12","author":"Giroud","year":"2015","journal-title":"Int J Environ Res Public Health"},{"issue":"6","key":"10.1016\/j.clinthera.2018.03.013_bib10","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1177\/0706743716645288","article-title":"What Can Rats Tell Us about Adolescent Cannabis Exposure? Insights from Preclinical Research","volume":"61","author":"Renard","year":"2016","journal-title":"Can J Psychiatry"},{"issue":"7","key":"10.1016\/j.clinthera.2018.03.013_bib11","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.biopsych.2015.07.024","article-title":"The impact of exposure to cannabinoids in adolescence: insights from animal models","volume":"79","author":"Rubino","year":"2016","journal-title":"Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.clinthera.2018.03.013_bib12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1369-1600.2008.00110.x","article-title":"Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure","volume":"13","author":"Schneider","year":"2008","journal-title":"Addict Biol"},{"key":"10.1016\/j.clinthera.2018.03.013_bib13","article-title":"Rates and predictors of conversion to schizophrenia or bipolar disorder following substance-induced psychosis","author":"Starzer","year":"2017","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2018.03.013_bib14","series-title":"The Complex Connection Between Cannabis and Schizophrenia","first-page":"75","article-title":"Psychotomimetic and cognitive effects of \u0394 9-tetrahydrocannabinol in laboratory settings","author":"Cahill","year":"2018"},{"issue":"3","key":"10.1016\/j.clinthera.2018.03.013_bib15","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0091-3057(90)90028-G","article-title":"Acute and residual effects of marijuana: profiles of plasma THC levels, physiological, subjective, and performance measures","volume":"37","author":"Heishman","year":"1990","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.clinthera.2018.03.013_bib16","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1038\/sj.npp.1301643","article-title":"Blunted psychotomimetic and amnestic effects of Delta-9-tetrahydrocannabinol in frequent users of cannabis","volume":"33","author":"D'Souza","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.clinthera.2018.03.013_bib17","series-title":"Handbook of Cannabis","first-page":"189","article-title":"Effects of phytocannabinoids on anxiety, mood, and the endocrine system","author":"Patel","year":"2014"},{"key":"10.1016\/j.clinthera.2018.03.013_bib18","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrn4036","article-title":"The endocannabinoid system in guarding against fear, anxiety and stress","volume":"16","author":"Lutz","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.clinthera.2018.03.013_bib19","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.tips.2009.06.006","article-title":"The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants","volume":"30","author":"Hill","year":"2009","journal-title":"Trends Pharmacol Sci"},{"issue":"9600","key":"10.1016\/j.clinthera.2018.03.013_bib20","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/S0140-6736(07)61721-8","article-title":"Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials","volume":"370","author":"Christensen","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2018.03.013_bib21","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.biopsych.2016.01.011","article-title":"Human laboratory studies on cannabinoids and psychosis","volume":"79","author":"Sherif","year":"2016","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.clinthera.2018.03.013_bib22","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1080\/10826084.2016.1263663","article-title":"Clinical characteristics of synthetic cannabinoid use in a large urban psychiatric emergency setting","volume":"52","author":"Manseau","year":"2017","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.clinthera.2018.03.013_bib23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa1610300","article-title":"\u201cZombie\u201d outbreak caused by the synthetic cannabinoid AMB-FUBINACA in New York","volume":"376","author":"Adams","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2018.03.013_bib24","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.3109\/00048670903179095","article-title":"Subjective effects of cannabis before the first psychotic episode","volume":"43","author":"Peters","year":"2009","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.clinthera.2018.03.013_bib25","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00213-006-0508-y","article-title":"The acute effects of cannabinoids on memory in humans: a review","volume":"188","author":"Ranganathan","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.clinthera.2018.03.013_bib26","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1177\/0269881108092393","article-title":"Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users","volume":"23","author":"Ramaekers","year":"2009","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.clinthera.2018.03.013_bib27","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.biopsych.2015.12.002","article-title":"Acute and Chronic Effects of Cannabinoids on Human Cognition-A Systematic Review","volume":"79","author":"Broyd","year":"2016","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.clinthera.2018.03.013_bib28","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.pnpbp.2017.06.019","article-title":"Tetrahydrocannabinol (THC)impairs encoding but not retrieval of verbal information","volume":"79","author":"Ranganathan","year":"2017","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.clinthera.2018.03.013_bib29","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.neuropharm.2015.10.021","article-title":"Dopamine-dependent CB1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice","volume":"101","author":"Madeo","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.clinthera.2018.03.013_bib30","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.biopsych.2008.05.011","article-title":"Neural basis of \u0394-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition","volume":"64","author":"Borgwardt","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.clinthera.2018.03.013_bib31","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.aap.2007.10.011","article-title":"Effects of THC on driving performance, physiological state and subjective feelings relative to alcohol","volume":"40","author":"Ronen","year":"2008","journal-title":"Accid Anal Prevent"},{"key":"10.1016\/j.clinthera.2018.03.013_bib32","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.forsciint.2014.12.018","article-title":"The combined effects of alcohol and cannabis on driving: Impact on crash risk","volume":"248","author":"Dubois","year":"2015","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.clinthera.2018.03.013_bib33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/1874473710801010081","article-title":"The chronic effects of cannabis on memory in humans: a review","author":"Solowij","year":"2008","journal-title":"Curr Drug Abuse Rev"},{"key":"10.1016\/j.clinthera.2018.03.013_bib34","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1017\/S1355617703950016","article-title":"Non-acute (residual) neurocognitive effects of cannabis use: a meta-analytic study","volume":"9","author":"Grant","year":"2003","journal-title":"J Int Neuropsychol Soc"},{"key":"10.1016\/j.clinthera.2018.03.013_bib35","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1206820109","article-title":"Persistent cannabis users show neuropsychological decline from childhood to midlife","volume":"109","author":"Meier","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl","key":"10.1016\/j.clinthera.2018.03.013_bib36","doi-asserted-by":"crossref","first-page":"41S","DOI":"10.1002\/j.1552-4604.2002.tb06002.x","article-title":"Cognitive measures in long-term cannabis users","volume":"42","author":"Pope","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2018.03.013_bib37","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1037\/a0029117","article-title":"Residual effects of cannabis use on neurocognitive performance after prolonged abstinence: a meta-analysis","volume":"20","author":"Schreiner","year":"2012","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1016\/j.clinthera.2018.03.013_bib38","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrn.2016.28","article-title":"Keep off the grass? Cannabis, cognition and addiction","volume":"17","author":"Curran","year":"2016","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.clinthera.2018.03.013_bib39","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1176\/appi.ajp.2013.12060782","article-title":"DSM-5 criteria for substance use disorders: recommendations and rationale","volume":"170","author":"Hasin","year":"2013","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2018.03.013_bib40","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1001\/jamapsychiatry.2015.3229","article-title":"Cannabis use and risk of psychiatric disorders: prospective evidence from a US national longitudinal study","volume":"73","author":"Blanco","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.clinthera.2018.03.013_bib41","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1017\/S0033291715001178","article-title":"Examining the profile of high-potency cannabis and its association with severity of cannabis dependence","volume":"45","author":"Freeman","year":"2015","journal-title":"Psychol Med"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2018.03.013_bib42","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.neuropharm.2008.07.018","article-title":"The endocannabinoid system as a target for the treatment of cannabis dependence","volume":"56","author":"Clapper","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.clinthera.2018.03.013_bib43","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00213-008-1422-2","article-title":"The effects of cannabinoids on serum cortisol and prolactin in humans","volume":"203","author":"Ranganathan","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.clinthera.2018.03.013_bib44","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1037\/a0027622","article-title":"Prevalence of cannabis use disorder diagnoses among veterans in 2002. 2008, and 2009","volume":"9","author":"Bonn-Miller","year":"2012","journal-title":"Psychol Serv"},{"key":"10.1016\/j.clinthera.2018.03.013_bib45","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.drugalcdep.2006.04.014","article-title":"Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms","volume":"86","author":"Budney","year":"2007","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.clinthera.2018.03.013_bib46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/SAR.S109576","article-title":"The cannabis withdrawal syndrome: current insights","volume":"8","author":"Bonnet","year":"2017","journal-title":"Subst Abuse Rehabil"},{"key":"10.1016\/j.clinthera.2018.03.013_bib47","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bpsc.2015.09.008","article-title":"Rapid changes in CB1 receptor availability in cannabis dependent males after abstinence from cannabis","volume":"1","author":"D'Souza","year":"2016","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"10.1016\/j.clinthera.2018.03.013_bib48","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/mp.2012.100","article-title":"Reduced cannabinoid CB1 receptor binding in alcohol dependence measured with positron emission tomography","volume":"18","author":"Hirvonen","year":"2013","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.clinthera.2018.03.013_bib49","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1124\/mol.105.019612","article-title":"Prolonged recovery rate of CB1 receptor adaptation after cessation of long-term cannabinoid administration","volume":"70","author":"Sim-Selley","year":"2006","journal-title":"Mol Pharmacol"},{"issue":"9698","key":"10.1016\/j.clinthera.2018.03.013_bib50","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0140-6736(09)61037-0","article-title":"Adverse health effects of non-medical cannabis use","volume":"374","author":"Hall","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2018.03.013_bib51","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1369-1600.2010.00243.x","article-title":"Individual differences in substance dependence: at the intersection of brain, behaviour and cognition","volume":"16","author":"Baker","year":"2011","journal-title":"Addict Biol"},{"key":"10.1016\/j.clinthera.2018.03.013_bib52","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.biopsych.2016.02.007","article-title":"Marijuana and madness: Associations between cannabinoids and psychosis","volume":"79","author":"Ranganathan","year":"2016","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.clinthera.2018.03.013_bib53","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.biopsych.2005.01.026","article-title":"Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction","volume":"57","author":"Caspi","year":"2005","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.clinthera.2018.03.013_bib54","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.schres.2013.07.020","article-title":"The effect of childhood maltreatment and cannabis use on adult psychotic symptoms is modified by the COMT ValMet polymorphism","volume":"150","author":"Vinkers","year":"2013","journal-title":"Schizophr Res"},{"key":"10.1016\/j.clinthera.2018.03.013_bib55","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/archgenpsychiatry.2011.5","article-title":"Cannabis use and earlier onset of psychosis: a systematic meta-analysis","volume":"68","author":"Large","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.clinthera.2018.03.013_bib56","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1093\/schbul\/sbt181","article-title":"Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users","volume":"40","author":"Di Forti","year":"2014","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.clinthera.2018.03.013_bib57","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1177\/0269881116658990","article-title":"Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis","volume":"30","author":"Bassir Nia","year":"2016","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.clinthera.2018.03.013_bib58","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archpsyc.64.1.57","article-title":"Effects of co-occurring cannabis use disorders on the course of bipolar disorder after a first hospitalization for mania","volume":"64","author":"Strakowski","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.clinthera.2018.03.013_bib59","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1017\/S0033291713001438","article-title":"The association between cannabis use and depression: a systematic review and meta-analysis of longitudinal studies","volume":"44","author":"Lev-Ran","year":"2014","journal-title":"Psychol Med"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291818301061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291818301061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T09:54:10Z","timestamp":1545213250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291818301061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":59,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0149291818301061"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2018.03.013","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Psychiatric Consequences of Cannabinoids","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2018.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}